BACKGROUND: The aim of this study was to evaluate oncologic outcomes and adverse events for @entity1 with @entity263 after treatment by high-intensity focused ultrasound (HIFU). METHODS: Between February 2004 and August 2010, @entity1 with @entity263 who underwent HIFU treatment were reviewed about oncologic outcomes and complications. Biochemical recurrence (BCR) was defined as prostate-specific antigen (PSA) nadir plus 1.2   ng/ml. Kaplan-Meier analysis was performed to evaluate BCR- and disease progression-free survival according to risk stratification. Predictors for BCR and disease progression were identified using the Cox-proportional hazard method. RESULTS: The overall BCR rate was 59.5%, and median time to BCR was 13.8 months. The 5-year BCR-free survival rates of the low-, intermediate-, and high-risk groups were 66.3, 40.2, and 21.0% (P   =   0.001), respectively, and the 5-year disease progression-free survival rates were 73.5, 46.0, and 29.2%, respectively (P   =   0.008). Multivariate analysis showed that risk stratification, PSA nadir, and time to PSA nadir were significant predictors of BCR and disease progression. In the first 3 months post-op, 11 @entity1 (8.7%) had complications. There were no @entity1 who required blood transfusions or who had wound problems, @entity64 , @entity1150 , or @entity29 . CONCLUSIONS: HIFU treatment does not provide effective oncologic outcomes even in low risk @entity1 with @entity263 as well as in the intermediate or high risk groups. Therefore, @entity1 selected to undergo HIFU treatment for @entity263 must be very carefully chosen. On the other hand, HIFU treatment for @entity263 had a very low rate of complications.

Seven years of experience with high-intensity focused ultrasound for XXXX : advantages and limitations.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity263 :: ('MESH:D011471', 'Disease') :: ['prostate cancer'] @entity29 :: ('MESH:D015212', 'Disease') :: ['bowel dysfunction'] @entity1150 :: ('MESH:D020246', 'Disease') :: ['deep vein thrombosis']
@entity263 :: (MESH:D011471,Disease) :: ['prostate cancer']
